GENE ONLINE|News &
Opinion
Blog

South Korea
Regulatory AstraZenecaAsthma
AstraZeneca’s severe asthma drug Tezspire has been granted market authorization in South Korea
2023-12-25
Asia-Pacific global collaboration
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Sept 4-Sept 8
2023-09-12
Trials & Approvals IgA NephropathySouth Korea
South Korea Puts Everest Medicines’ Nefecon On Fast Track
2023-02-10
Go Prime Biomanufacturing
Will Biden’s Biomanufacturing Initiative Kill Korean Partnership?
2022-10-12
Special KoreaBio
Scaling up Korea’s Biotech Presence in The Global Value Chain, an Interview with Seung Kyou Lee, Vice President of KoreaBIO
2022-08-31
Special BIOplus2022koreabiotechGlobal Events
BIOPLUS-INTERPHEX Korea 2022: The Now and Tomorrow of Korea’s Biotechnology Industry
2022-08-15
Special South Korea
Korean Companies Occupying South Korea’s Diverse Biotech Landscape
2022-08-03
Special KoreaBio
South Korea’s Biotech Industry：Trends, Landscape, and Clusters Overview
2022-08-01
Special BIOplus
BIX 2022 – Opening Doors to Korea’s Biopharmaceutical Industry
2022-07-27
Deals South Korea
LOTTE Corporation Buys Bristol Myers Squibb’s New York Manufacturing Plant for $160 Million
2022-05-16
Trials & Approvals Diabetes
Novo Nordisk’s Type 2 Diabetes Drug Gets Greenlight in Korea
2022-05-04
Asia-Pacific AI
Israeli and South Korean Companies Collaborate in Drug Innovation with Data Platform
2022-04-19
Deals Vaccine
Bavarian Nordic Establishes Asia Link for Its RSV Vaccines
2022-03-24
Deals South Korea
Alliance Formed: SV Investment and Orange Grove Bio Jointly Source and Develop Novel Medications in the U.S. and Korea
2022-03-16
1 2 3 4
LATEST
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top